End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.76 CNY | -0.75% | -3.56% | +8.69% |
04-24 | Runben Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 1.35B 186M 14.61B | Sales 2025 * | 1.72B 237M 18.65B | Capitalization | 8.06B 1.11B 87.36B |
---|---|---|---|---|---|
Net income 2024 * | 287M 39.63M 3.11B | Net income 2025 * | 360M 49.71M 3.9B | EV / Sales 2024 * | 5.98 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 4.68 x |
P/E ratio 2024 * |
28
x | P/E ratio 2025 * |
22.4
x | Employees | 917 |
Yield 2024 * |
0.97% | Yield 2025 * |
1.21% | Free-Float | 15.26% |
1 day | -0.75% | ||
1 week | -3.56% | ||
Current month | +6.07% | ||
1 month | +9.78% | ||
3 months | +24.35% | ||
6 months | +8.87% | ||
Current year | +8.69% |
Date | Price | Change | Volume |
---|---|---|---|
23/05/24 | 19.76 | -0.75% | 1 497 446 |
23/05/24 | 19.91 | -2.21% | 1,926,496 |
22/05/24 | 20.36 | -1.36% | 2,401,252 |
21/05/24 | 20.64 | +2.13% | 2,185,756 |
20/05/24 | 20.21 | -0.69% | 1,742,789 |
End-of-day quote Shanghai S.E., May 23, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 603193 Stock